Mirada will be demonstrating their latest range of software tools for PET/MRI, PET/CT, Tumor Board and Amyloid image reading in their technical exhibit (Booth #320).

For more information, please contact:


Mirada Medical
US/Worldwide: Robert Ripley
tel: (440) 591-8638
Insource Communications
rripley@insourceinc.com
enquiries@mirada-medical.com
www.mirada-medical.com

U.S. Headquarters:
Mirada Medical USA, Inc.
999 18th Street
Suite 2025N
Denver, CO 80202
Tel: (303) 379-9228

World Headquarters:
Oxford Centre for Innovation
New Road, Oxford
OX1 1BY
United Kingdom
Tel: +44(0)1865 261410

About Mirada Medical Ltd

Mirada Medical is a leading international brand in medical imaging. The company develops advanced software applications which help healthcare professionals use medical images more effectively and efficiently to improve cancer care. Mirada's products are used across diagnostic radiology, molecular imaging, radiation oncology, medical oncology, tumor board and elsewhere.

The company specializes in simplifying technically complex image processing tasks, allowing clinicians to more confidently diagnose disease, assess response to treatment and plan radiation therapy or surgical intervention. Mirada's advanced software products are available throughout the world under its own brand, and on an OEM basis through a select number of the world's leading healthcare companies.

Mirada Medical was originally spun out of the University of Oxford. The company's technologies and products continue to be developed by their team of specialists, engineers and world-renowned scientists at Mirada's world headquarters in Oxford, England.

Mirada Medical, RTx, Casemeeting, Caseaccess and XD3 are all trademarks of Mirada Medical Ltd.

Back to HCB News

More HCB News